These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16581679)

  • 21. Common hyperpigmentation disorders in adults: Part II. Melanoma, seborrheic keratoses, acanthosis nigricans, melasma, diabetic dermopathy, tinea versicolor, and postinflammatory hyperpigmentation.
    Stulberg DL; Clark N; Tovey D
    Am Fam Physician; 2003 Nov; 68(10):1963-8. PubMed ID: 14655805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.
    Callender VD; St Surin-Lord S; Davis EC; Maclin M
    Am J Clin Dermatol; 2011 Apr; 12(2):87-99. PubMed ID: 21348540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of pigmented lesions of neurofibromatosis 1 with intense pulsed-radio frequency in combination with topical application of vitamin D3 ointment.
    Yoshida Y; Sato N; Furumura M; Nakayama J
    J Dermatol; 2007 Apr; 34(4):227-30. PubMed ID: 17352718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postinflammatory hyperpigmentation: A comprehensive overview: Treatment options and prevention.
    Chaowattanapanit S; Silpa-Archa N; Kohli I; Lim HW; Hamzavi I
    J Am Acad Dermatol; 2017 Oct; 77(4):607-621. PubMed ID: 28917452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation.
    Ko D; Wang RF; Ozog D; Lim HW; Mohammad TF
    J Am Acad Dermatol; 2023 Feb; 88(2):291-320. PubMed ID: 35158001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lasers].
    Passeron T
    Ann Dermatol Venereol; 2012 Nov; 139 Suppl 3():S108-14. PubMed ID: 23260518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Periocular hyperpigmentation: a review of etiology and current treatment options.
    Alsaad SM; Mikhail M
    J Drugs Dermatol; 2013 Feb; 12(2):154-7. PubMed ID: 23377386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperpigmentation: types, diagnostics and targeted treatment options.
    Nieuweboer-Krobotova L
    J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():2-4. PubMed ID: 23205538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical peels.
    Monheit GD
    Skin Therapy Lett; 2004 Feb; 9(2):6-11. PubMed ID: 14749844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical peeling with trichloroacetic acid and lactic acid for infraorbital dark circles.
    Vavouli C; Katsambas A; Gregoriou S; Teodor A; Salavastru C; Alexandru A; Kontochristopoulos G
    J Cosmet Dermatol; 2013 Sep; 12(3):204-9. PubMed ID: 23992162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperpigmentation Disorders in Hispanic Population in the United States.
    Rendon MI
    J Drugs Dermatol; 2019 Mar; 18(3):s112-114. PubMed ID: 30909363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperpigmentation Disorders in Hispanic Population in the United States.
    Rendon MI
    J Drugs Dermatol; 2019 Mar; 18(3):s112-114. PubMed ID: 30909362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nevus of Ota successfully treated by fractional photothermolysis using a fractionated 1440-nm Nd:YAG laser.
    Kouba DJ; Fincher EF; Moy RL
    Arch Dermatol; 2008 Feb; 144(2):156-8. PubMed ID: 18283171
    [No Abstract]   [Full Text] [Related]  

  • 34. Incorporating skin care into a facial plastic surgery practice.
    TerKonda RP
    Facial Plast Surg; 2004 Feb; 20(1):3-9. PubMed ID: 15034808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of hyperpigmentation in darker racial ethnic groups.
    Grimes PE
    Semin Cutan Med Surg; 2009 Jun; 28(2):77-85. PubMed ID: 19608057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Focal trichloroacetic acid peel method for benign pigmented lesions in dark-skinned patients.
    Chun EY; Lee JB; Lee KH
    Dermatol Surg; 2004 Apr; 30(4 Pt 1):512-6; discussion 516. PubMed ID: 15056140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periorbital hyperpigmentation: review of etiology, medical evaluation, and aesthetic treatment.
    Roberts WE
    J Drugs Dermatol; 2014 Apr; 13(4):472-82. PubMed ID: 24719068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypermelanoses of the newborn and of the infant.
    Taïeb A; Boralevi F
    Dermatol Clin; 2007 Jul; 25(3):327-36, viii. PubMed ID: 17662898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperpigmentation: a review of common treatment options.
    Cayce KA; Feldman SR; McMichael AJ
    J Drugs Dermatol; 2004; 3(6):668-73. PubMed ID: 15624750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early serial Q-switched ruby laser therapy for medium-sized to giant congenital melanocytic naevi.
    Kishi K; Okabe K; Ninomiya R; Konno E; Hattori N; Katsube K; Imanish N; Nakajima H; Nakajima T
    Br J Dermatol; 2009 Aug; 161(2):345-52. PubMed ID: 19438478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.